Easier access to addiction treatment: temporary removal of buprenorphine controls.
This bill aims to temporarily exempt buprenorphine, a medication used for opioid use disorder, from the Suspicious Orders Report System (SORS). This change is intended to make it easier for pharmacies to stock and dispense the drug, directly increasing patient access to essential treatment during the ongoing opioid public health emergency. After the emergency ends, the government will assess whether this temporary exemption improved access and should become permanent.
Key points
Buprenorphine (used for addiction treatment) is temporarily removed from the Suspicious Orders Report System (SORS) for the duration of the opioid public health emergency.
Consequence for citizens: Pharmacies should face fewer hurdles in stocking buprenorphine, leading to easier and faster access to treatment for individuals with opioid use disorder.
After the opioid crisis emergency expires, the government must report on whether the exemption increased access and recommend if it should remain permanent.
Expired
Additional Information
Print number: 118_S_5271
Sponsor: Sen. Heinrich, Martin [D-NM]
Process start date: 2024-09-25